She earned her PhD from the University of British Columbia in Experimental Medicine investigating the pivotal innate immune mediators of inflammation in the context of toxic shock syndrome. Dr. Kalyan was subsequently awarded a 3-year fellowship from the Alexander von Humboldt Foundation to conduct research at the Institute of Immunology in Kiel, Germany. Her research interests include determining how to restore immune function in the context of cancer and chronic inflammatory diseases and understanding how drug therapies commonly used to treat chronic degenerative disorders affect immunity.